Cardiovascular Diseases Clinical Trial
Official title:
Using Digital Data to Predict Cardiovascular Health and Health Care Utilization
| NCT number | NCT04574882 |
| Other study ID # | 833699 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | September 25, 2020 |
| Est. completion date | June 1, 2024 |
| Verified date | January 2024 |
| Source | University of Pennsylvania |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This project seeks to identify and characterize features derived from digital data (e.g. social media, online search, mobile media) which are associated with coronary heart disease (CHD) and related risk factors, and develop models that use digital data and conventional predictive models to predict CHD risk and health care utilization.
| Status | Recruiting |
| Enrollment | 1000 |
| Est. completion date | June 1, 2024 |
| Est. primary completion date | May 30, 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 30 Years to 74 Years |
| Eligibility | Inclusion Criteria: - 30 - 74 years of age - Willing to sign informed consent - Primarily English speaking (for language analysis) - Has an account on any of the following digital data platforms (Facebook, Instagram, Twitter Reddit, Google (gmail), or smartphone or wearable device such as Apple Health, Fitbit, Samsung Health, MapMyFitness or Garmin) and willing to share data - If has social media account, Instagram or Facebook, willing to share historical and prospective data (60 days) If has Google (gmail) account, willing to download and share google takeout zip file - If has smartphone or wearable device, willing to share step data - Willing to share access to medical health records - Willing to share healthcare insurance information Exclusion Criteria: - Patient does not meet age inclusion criteria above - Does not use and post on digital data sources we are studying or unwilling to donate data - Patient is in severe distress, e.g. respiratory, physical, or emotional distress - Patient is intoxicated, unconscious, or unable to appropriately respond to questions |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Pennsylvania Health System | Philadelphia | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pennsylvania |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | CHD event | Reliability in predicting CHD related event in patient as measured by Framingham Risk Score.
The Framingham Risk Score (FRS) is a validated means of predicting cardiovascular disease (CVD) risk. Input variables include age, cigarette smoking, total cholesterol, HDL cholesterol, systolic blood pressure measurement and treatment for hypertension. Point values are calculated based on each of these risks. A 10-year risk score can be derived as a percentage. Risk scores range from 0-20%. Low Risk: Less than 10% risk that you will develop a heart attack or die from coronary disease in the next 10 years. Intermediate risk: A 10 to 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years. High Risk: A greater than 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years. |
Through study completion, an average of 3 years | |
| Other | Health care utilization | Prediction of cost for health care utilization between heart disease and non- heart disease subjects measured by insurance claims data | Through study completion, an average of 3 years | |
| Primary | Latent Dirichlet Allocation Topics - topics / themes discussed between patients with and without heart disease | The primary outcome is topics and features (derived using the Latent Dirichlet Allocation [LDA] method for clustering language data). | Through study completion, an average of 3 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|